# Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

> **NCT03223012** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 116 (actual)

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis (UC)
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis
- Psoriasis
- Ankylosing Spondylitis (AS)
- Non-radiographic Axial Spondyloarthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03223012
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2020-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03223012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03223012, "Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03223012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*